Longeveron Inc. has filed an updated Schedule 13G/A with the SEC, revealing changes in beneficial ownership. The filing, submitted on November 5, 2026, indicates that Integrated Core Strategies (US) LLC and its affiliates hold no shares in the company. This update is significant as it reflects the evolving landscape of ownership in the pharmaceutical preparations sector.

Background

Longeveron Inc., trading under the ticker LGVN on the Nasdaq, is categorized under the SIC code 2834, which pertains to Pharmaceutical Preparations. The company is based in Miami, Florida, and has undergone several recent filings, including an 8-K on the same day as the Schedule 13G/A filing.

What the Filing Says

The filing states that Integrated Core Strategies (US) LLC, along with Millennium Management LLC and Millennium Group Management LLC, collectively reported no beneficial ownership of shares in Longeveron Inc. The filing notes, "The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities." This suggests a passive investment strategy rather than an active pursuit of control.

Impact

This filing may affect perceptions among investors and stakeholders regarding Longeveron's ownership structure. With no shares held by these significant entities, it raises questions about the future direction of the company and its governance. The absence of ownership may also influence Longeveron's market positioning within the competitive pharmaceutical landscape.

What's Next

The filing does not specify what happens next regarding Longeveron's strategic initiatives or potential changes in ownership dynamics. Investors will likely be watching closely for further updates or filings that could provide additional insights into the company's direction.